GGrantIndex
← Search

PHASE I TRIAL OF SAFETY, TOLERANCE &PHARMACOKINETICS OF ORAL NELFINAVIR

$207,266M01FY2001RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →